Page last updated: 2024-10-26

e 4031 and Pituitary Neoplasms

e 4031 has been researched along with Pituitary Neoplasms in 2 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YC1
Wu, SN1
Weinsberg, F1
Bauer, CK1
Schwarz, JR1

Other Studies

2 other studies available for e 4031 and Pituitary Neoplasms

ArticleYear
Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells.
    European journal of pharmacology, 2003, Jan-01, Volume: 458, Issue:1-2

    Topics: 8,11,14-Eicosatrienoic Acid; alpha-Linolenic Acid; Amides; Animals; Arachidonic Acid; Arachidonic Ac

2003
The class III antiarrhythmic agent E-4031 selectively blocks the inactivating inward-rectifying potassium current in rat anterior pituitary tumor cells (GH3/B6 cells).
    Pflugers Archiv : European journal of physiology, 1997, Volume: 434, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Piperidines; Pituitary Neoplasms;

1997